EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS073-10766 
Organism
Homo sapiens 
Tissue/cell
GM19238 
Coordinate
chr3:186703610-186705540 
Target genes
Number: 4             
NameEnsembl ID
TF binding sites/motifs
Number: 30             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr3:186704970-186704988GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr3:186704939-186704957GGGAGGGAGGAAGAAAGA+6.06
EWSR1-FLI1MA0149.1chr3:186705030-186705048GAAAGAAAGGAAGAAAGA+6.22
EWSR1-FLI1MA0149.1chr3:186704982-186705000GGAGGGAAGGAAAGAAAA+6.33
EWSR1-FLI1MA0149.1chr3:186704935-186704953GGGAGGGAGGGAGGAAGA+6.36
EWSR1-FLI1MA0149.1chr3:186704923-186704941AGAAAGAAGGAAGGGAGG+6.59
EWSR1-FLI1MA0149.1chr3:186704927-186704945AGAAGGAAGGGAGGGAGG+6.71
EWSR1-FLI1MA0149.1chr3:186704974-186704992GGAGGGAGGGAGGGAAGG+6.94
EWSR1-FLI1MA0149.1chr3:186704931-186704949GGAAGGGAGGGAGGGAGG+7.08
EWSR1-FLI1MA0149.1chr3:186704911-186704929GAAAGGAAGGAAAGAAAG+7.36
EWSR1-FLI1MA0149.1chr3:186705021-186705039GGAAGAAAGGAAAGAAAG+7.37
EWSR1-FLI1MA0149.1chr3:186705001-186705019GAAAGAAAGCAAGGAAGG+7.41
EWSR1-FLI1MA0149.1chr3:186704978-186704996GGAGGGAGGGAAGGAAAG+7.62
EWSR1-FLI1MA0149.1chr3:186704915-186704933GGAAGGAAAGAAAGAAGG+7.69
EWSR1-FLI1MA0149.1chr3:186704919-186704937GGAAAGAAAGAAGGAAGG+7.87
EWSR1-FLI1MA0149.1chr3:186705005-186705023GAAAGCAAGGAAGGAAGG+8.03
EWSR1-FLI1MA0149.1chr3:186705009-186705027GCAAGGAAGGAAGGAAGA+8.26
EWSR1-FLI1MA0149.1chr3:186705017-186705035GGAAGGAAGAAAGGAAAG+8.5
EWSR1-FLI1MA0149.1chr3:186705013-186705031GGAAGGAAGGAAGAAAGG+9.25
ZNF263MA0528.1chr3:186704967-186704988CAGGGAGGGAGGGAGGGAGGG+6.02
ZNF263MA0528.1chr3:186704933-186704954AAGGGAGGGAGGGAGGAAGAA+6.03
ZNF263MA0528.1chr3:186705014-186705035GAAGGAAGGAAGAAAGGAAAG+6.11
ZNF263MA0528.1chr3:186705018-186705039GAAGGAAGAAAGGAAAGAAAG+6.21
ZNF263MA0528.1chr3:186704944-186704965GGAGGAAGAAAGAGAAAGAGA+6.36
ZNF263MA0528.1chr3:186704941-186704962GAGGGAGGAAGAAAGAGAAAG+6.42
ZNF263MA0528.1chr3:186704979-186705000GAGGGAGGGAAGGAAAGAAAA+6.4
ZNF263MA0528.1chr3:186704925-186704946AAAGAAGGAAGGGAGGGAGGG+6.65
ZNF263MA0528.1chr3:186704928-186704949GAAGGAAGGGAGGGAGGGAGG+7.38
ZNF263MA0528.1chr3:186704975-186704996GAGGGAGGGAGGGAAGGAAAG+7.41
ZNF263MA0528.1chr3:186704971-186704992GAGGGAGGGAGGGAGGGAAGG+7.63
Number of super-enhancer constituents: 16             
IDCoordinateTissue/cell
SE_07435chr3:186703222-186705601Brain_Hippocampus_Middle_150
SE_10196chr3:186703255-186705590CD19_Primary
SE_10855chr3:186691104-186754774CD20
SE_32534chr3:186703421-186705283GM12878
SE_33923chr3:186703461-186704195HCC1954
SE_40708chr3:186703316-186704840Left_Ventricle
SE_42364chr3:186703983-186704765Lung
SE_43633chr3:186703125-186707978MM1S
SE_48802chr3:186704004-186704697Right_Atrium
SE_58288chr3:186627032-186791622Ly1
SE_59164chr3:186703252-186764260Ly3
SE_60441chr3:186703232-186762793DHL6
SE_61008chr3:186703204-186764166HBL1
SE_62186chr3:186703447-186763111Toledo
SE_62245chr3:186702797-186764702Tonsil
SE_67440chr3:186703125-186707978MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr3186704800186704868
chr3186705053186705317
Number: 2             
IDChromosomeStartEnd
GH03I186985chr3186703189186704944
GH03I186987chr3186704989186705188
Enhancer Sequence
TCTGAGGGAG ATGTCACTGG GGGCTGGTCA TGTGGAAGCA GGAATCTTCC CCGTGTATGT 60
GGGCATTTCA GGACTGGCAG GAAGCTGGTC CCAGGGGAGG CTAAGCTGGG GAGGATGCCT 120
GAAAGGCATT AGTGGGAGGG AGTTTGAAAA AGACCCAGAG ACGCCTGTTT GAAATAAGTA 180
TTGGAAAGGA CTCTTTAGAT TTTGCAATTA GAAAGGCAGT TTCAGTGGAA TGATGTGAAC 240
CGACTTCAGT TATTTGAGGA ACCAGTAGAA AGTGGGGAAG TGTAAGCAAG TCAAGAGACC 300
CCGCCATAAG GAAGCAGAGA TTAGGTTGCC GTTTGAGGAA GTGATTTGTT TGAGGTATTT 360
TTTTTTAGCT CCACAAAATA TCATGTTTCG GGTGTGAGTA GGGATGGGGT AAATGACACA 420
CTAAGCTAAT AACATCCAAA CCAGCTTGTG AAACATCGTG CAAGTTATAT CTGGTTCATA 480
CCAAAGAGTC GCTACTCAGT CCAGGCCTCT ATCATGCCTG GCACATAGTG TTGAATATTG 540
TATTCAATAA ATATTCAACA GTAAATATTT GTTGAATACA GTATTAAATA CTATAGAATT 600
TAGACAGGTC CCTGTATCAA CAACAGCAAC AATGACCACC ACCACCACCA CCACCACCAC 660
AACAAAATAA CAAGAATGTC CAATGTAGGG GGTTGCTTTT TGATCCACTT GCCTTTGGCT 720
AGTGGTGTCT TTCTCTCCTT AGCGCCATAT TCTTCAGCAC TTTTCGGCAG CTGTATGTGG 780
TTCTATTTTG GTCTCCTCTT TACTGCACGG CGATTATGTT TTCAAGAGGC AAATCTTCAG 840
GGTGACTAGA GTGACACGTT ATCTGAGTTC TGGATGGAGG TAAAGGAATA TCACGGTGAG 900
TCTGGGGAAG CAAGGGGACA AGAGAGTTGG CCAAATGAGG CGGAAAGACC CCAGACTTGC 960
GATCAGAAGA ACCTGATGTC AAATCAGATG CATCTTATAG CAAGTCGAGC CACCTCTCTG 1020
AAACTTGAAT TTAAATGATC TAAGGTCATT TCCTTTGGAT TTTATAGAAA GAATAGTGTC 1080
AGGAGAAAAA GAAAAACAAG GAACCATGAC TTGCTAAACA TACTCAGAAC CAAAGGTTTT 1140
CTTTCTTTCC TTTTAAAAAA AAGTGATATA CAGTGAATAC AGGCTTAGTT CCCTAATGGT 1200
GGCAAATGAT GTAATGTTCA CAGATGTCCT GGGGGAAAAC AGAACAATCA ACTTCTATTT 1260
TACTCTTACC ATTTCTGAGA GAAGTCAGGC AGACTGCATA GGAAAGGAAG GAAAGAAAGA 1320
AGGAAGGGAG GGAGGGAGGA AGAAAGAGAA AGAGAGACAG GGAGGGAGGG AGGGAGGGAA 1380
GGAAAGAAAA GGAAAGAAAG CAAGGAAGGA AGGAAGAAAG GAAAGAAAGG AAGAAAGAAA 1440
GAAGAAAGAA AAGCCCCTAA GGTTAGTAAG TATCTTATGT CCCTGGAACT ACGCTAGGCA 1500
CATACATACC TTACCACCTT CCTTATCCAG TGAAGGGTAT TACATCAGTG TTTTAGGTAA 1560
CCTACCCAAG GTCCACAGCT AACAATGGGG AGAGAGGATA CAACAAGCCT TTGGGGGAGA 1620
AAATTGAAGC CCACGGCCCA CAAGAAATAA AGCCAAGAAA TGTAGTTGCT TAAAGTCAGC 1680
CAGATTCCCC AGCACCCAGC ATAGTGTCTT ATTCTTAGGA GAATTTGAGA AATATTTATT 1740
TATCTAAGGG ATGGTTGGTT GGTTGAACGA ATTACCTGAG GAAACCTGAA AATGTTTTTT 1800
GCTGAAGTGC TGTTGAAGGT CCTCAAGATC TTACGGAGAT GGGAGAAACC TAGGGGGAGA 1860
GAAATAAAAT TTAAATTTTC AAAAGGAATA ATTATAAACC AACTGTATCA GGCAGTAACT 1920
GAGTTGACCT 1930